Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 15:55:43 GMT 2023
by
admin
on
Sat Dec 16 15:55:43 GMT 2023
|
| Protein Type | VIRAL STRUCTURAL PROTEIN |
| Protein Sub Type | VIRAL ENVELOPE PROTEIN |
| Sequence Origin | VIRAL |
| Sequence Type | COMPLETE |
| Record UNII |
0EO1SV3LKY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
P0DTC2
Created by
admin on Sat Dec 16 15:55:43 GMT 2023 , Edited by admin on Sat Dec 16 15:55:43 GMT 2023
|
PRIMARY | |||
|
0EO1SV3LKY
Created by
admin on Sat Dec 16 15:55:43 GMT 2023 , Edited by admin on Sat Dec 16 15:55:43 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_3 | 1_124 |
| 1_119 | 1_154 |
| 1_279 | 1_289 |
| 1_324 | 1_349 |
| 1_367 | 1_420 |
| 1_379 | 1_513 |
| 1_526 | 1_578 |
| 1_605 | 1_637 |
| 1_650 | 1_659 |
| 2_3 | 2_124 |
| 2_119 | 2_154 |
| 2_279 | 2_289 |
| 2_324 | 2_349 |
| 2_367 | 2_420 |
| 2_379 | 2_513 |
| 2_526 | 2_578 |
| 2_605 | 2_637 |
| 2_650 | 2_659 |
| 3_3 | 3_124 |
| 3_119 | 3_154 |
| 3_279 | 3_289 |
| 3_324 | 3_349 |
| 3_367 | 3_420 |
| 3_379 | 3_513 |
| 3_526 | 3_578 |
| 3_605 | 3_637 |
| 3_650 | 3_659 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_5 |
| N | 1_49 |
| N | 1_62 |
| N | 1_110 |
| N | 1_137 |
| N | 1_153 |
| N | 1_222 |
| N | 1_270 |
| N | 1_319 |
| N | 1_331 |
| N | 1_591 |
| N | 1_604 |
| N | 1_645 |
| N | 2_5 |
| N | 2_49 |
| N | 2_62 |
| N | 2_110 |
| N | 2_137 |
| N | 2_153 |
| N | 2_222 |
| N | 2_270 |
| N | 2_319 |
| N | 2_331 |
| N | 2_591 |
| N | 2_604 |
| N | 2_645 |
| N | 3_5 |
| N | 3_49 |
| N | 3_62 |
| N | 3_110 |
| N | 3_137 |
| N | 3_153 |
| N | 3_222 |
| N | 3_270 |
| N | 3_319 |
| N | 3_331 |
| N | 3_591 |
| N | 3_604 |
| N | 3_645 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
In blocking studies, REGN10933, REGN10987, and REGN-COV2 mediated concentration-dependent blockade of SARS-CoV-2 RBD binding to human ACE2 with IC50
values in the subnanomolar range.
IN-VITRO
IC50
|
||
|
INHIBITOR -> TARGET | |||
|
|
LIGAND->TARGET |
Blocks attachment of the virus to human angiotensin-converting enzyme 2 (ACE2) receptors, preventing subsequent viral entry into human cells and viral replication.
|
||
|
|
INHIBITOR -> TARGET |
IN-VITRO
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|